Norovirus Management and Outcomes in a Multicenter Pediatric Kidney Transplant Population
Pediatric Transplantation · 2024
DOI: 10.1111/petr.14821 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Pediatric Transplantation, 2024. Verfasst von Rachel M Engen und 3 weiteren Autor:innen. Beteiligte Einrichtung: University of Wisconsin Madison, Madison, Wisconsin, USA. Hauptthemen laut MEDLINE: Kidney Transplantation, Caliciviridae Infections, Norovirus, Diarrhea. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Norovirus is the most common cause of viral gastroenteritis. Studies in adult kidney recipients have documented significant morbidity associated with norovirus infection, but there are few studies in pediatric recipients.
Methods
Multicenter retrospective cohort study of pediatric kidney transplant recipients with norovirus, confirmed by stool PCR, between January 1, 2008, and December 31, 2018. Outcomes of interest included duration of diarrhea, incidence of chronic diarrhea, management strategies, and graft function.
Results
Forty pediatric kidney transplant recipients from four centers were identified for inclusion. Median age at transplant was 5.4 years (IQR 2.2–11.2 years), and median time post‐transplant was 1.9 years (IQR 0.8–3.8 years). Median diarrheal duration was 16 days (IQR 6.0–41.5 days); 15 patients (43%) had acute diarrhea, 8 (23%) had persistent, and 12 (30%) had chronic diarrhea. Twenty‐one (53%) patients developed acute kidney injury. Thirty‐five (88%) patients required supplemental fluids, 8 (20%) patients underwent immunosuppression reduction for a median of 22 days, 5 (13%) were treated with nitazoxanide, and 5 (13%) received oral immunoglobulin. Acute rejection was diagnosed in 3 (8%) patients within 6 months of norovirus diagnosis. We observed no sustained decline in eGFR at 12 months after diarrhea resolution (median eGFR difference: 2.8 mL/min/1.73 m 2 [IQR: −17.1, 7.4]). Of the patients in the cohort, two lost their graft at 6.8 and 30.0 months after the onset of diarrhea.
Conclusion
Norovirus is associated with significant morbidity in pediatric kidney transplant recipients. Various treatment interventions are being employed for norovirus infection. Larger studies, both observational and interventional, are needed to determine the optimal treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of Wisconsin Madison, Madison, Wisconsin, USA.
- University of California San Diego, San Diego, California, USA.
- University of Minnesota Clinical and Translational Science Institute, Minneapolis, Minnesota, USA.
- University of Minnesota, Minneapolis, Minnesota, USA.
ORCID-Profile: Rachel M Engen, Michelle Keyser, Ziou Jiang, Sarah Kizilbash
Zitieren
APA
Engen, R. M., Keyser, M., Jiang, Z., & Kizilbash, S. (2024). Norovirus Management and Outcomes in a Multicenter Pediatric Kidney Transplant Population. Pediatric Transplantation. https://doi.org/10.1111/petr.14821
Vancouver
Engen RM, Keyser M, Jiang Z, Kizilbash S. Norovirus Management and Outcomes in a Multicenter Pediatric Kidney Transplant Population. Pediatric Transplantation. 2024. doi:10.1111/petr.14821
BibTeX
@article{Engen2024,
author = {Engen, Rachel M and Keyser, Michelle and Jiang, Ziou and Kizilbash, Sarah},
title = {Norovirus Management and Outcomes in a Multicenter Pediatric Kidney Transplant Population},
journal = {Pediatric Transplantation},
year = {2024},
doi = {10.1111/petr.14821}
}
EUVIMED